Treatment of ophthalmic conditions with mineralcorticoids

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/56 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2562356

The present invention provides a method of treatment of an individual with an ophthalmic condition comprising the step of: administering to the individual a therapeutically effective amount of a compound capable of modulating the activity of mineralocorticoid receptors within cells or tissue located in an eye or adjacent to an eye in the individual to be treated. Preferably, said compound is an anti-oedematous steroid, more preferably a mineralocorticoid.

Une méthode de traitement d'un individu souffrant d'une pathologie ophtalmique consistant à: administrer à l'individu une quantité thérapeutiquement efficace d'un composé apte à moduler l'activité des récepteurs de minéralocorticoïdes au sein des cellules ou d'un tissu se trouvant dans l'oeil ou adjacent à l'oeil de l'individu soumis au traitement. Le composé est de préférence, un stéroïde anti-oedémateux, de préférence un minéralocorticoïde.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of ophthalmic conditions with mineralcorticoids does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of ophthalmic conditions with mineralcorticoids, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of ophthalmic conditions with mineralcorticoids will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1773267

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.